Cargando…
Follow our path with asparaginase activity: one technique, but different uses in clinical practice
Acute lymphoblastic leukemia is the most common childhood malignancy. One of the drugs used in the treatment is Asparaginase, and monitoring of its activity levels enables better outcomes. Since 2018, our laboratory has been working to establish a regular analysis of activity. This implementation al...
Autores principales: | Cecconello, Daiane Keller, Rechenmacher, Ciliana, Silva, Klerize Anecely de Souza, Scherer, Fernanda Fetter, Prates, Thomas Dal Bem, Marques, Rebeca Ferreira, Daudt, Liane Esteves, Michalowski, Mariana Bohns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9635150/ https://www.ncbi.nlm.nih.gov/pubmed/36333762 http://dx.doi.org/10.1186/s40164-022-00351-5 |
Ejemplares similares
-
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center
por: Cecconello, Daiane Keller, et al.
Publicado: (2020) -
Asparaginase: an old drug with new questions
por: Cecconello, Daiane Keller, et al.
Publicado: (2020) -
Influence of minimal residual disease by multiparametric flow cytometry at day 15 of induction in risk stratification of children with B-cell acute lymphoblastic leukemia treated at a referral hospital in southern Brazil
por: Silva, Klerize Anecely de Souza, et al.
Publicado: (2020) -
From H1N1 to COVID-19: What we have seen in children with hemoglobinopathies
por: Oliveira, Claudia de Melo, et al.
Publicado: (2022) -
Allergic reactions to asparaginase: retrospective cohort study in pediatric patients with acute lymphoid leukemia
por: Battistel, Ana Paula, et al.
Publicado: (2021)